Deafness

Deafness is the most common sensory deficit. The Clinical Diagnostics Division of our laboratories is a CLIA-certified, Joint Commission accredited laboratory that provides to clinicians throughout the world mutation screening of several genes that have been implicated in deafness.

Renal Disease

The Clinical Diagnostics Division also provides to clinicians mutation screening of genes that have been implicated in two rare kidney diseases, Membranoproliferative Glomerulonephritis Type 2 or Dense Deposit Disease (MPGNII/DDD) and atypical Hemolytic Uremic Syndrome (aHUS). 

The objective in providing these services is to improve patient care by expediting the translation of basic science research to the clinical arena.

The Research Division of Dr Smith’s lab focuses on the human genetics of deafness and two rare kidney diseases, MPGNII/DDD and aHUS.

The objective of the Molecular Otolaryngology Research Laboratories (MORL) is to improve health care for deaf persons and their families. To meet this goal, the MORL has a Clinical Diagnostics Division and a Basic Research Division.


Clinical Diagnostics Division
Basic Research Division